Why the study?
Numerous controversies persist in the diagnosis and management of valvular heart disease, including treatment thresholds and risk stratification, where multimodality cardiac imaging may provide insights.
Multimodality cardiac imaging plays a crucial role in addressing ongoing controversies in the diagnosis and management of various valvular heart diseases.
Answers are grounded in this paper and cite their sources.
Highlights role of multimodality imaging in valvular controversies; leaves open need for prospective validation before practice change.
Numerous controversies still exist in the diagnosis and management of valvular heart disease, for example, the benefit of treating moderate aortic stenosis (AS) or asymptomatic, severe AS and the appropriate selection criteria for transcatheter edge-to-edge mitral valve repair. While numerous imaging parameters have been linked to the risk of sudden cardiac death in mitral valve prolapse, their relative merits are unknown and this is a challenging population to risk-stratify. No large, randomized data exist to guide selection of patients for transcatheter repair of tricuspid regurgitation or valve intervention in severe pulmonary regurgitation. Multimodality cardiac imaging provides unique insights into these important questions.
No takes yet. Share an insight, caveat, or question.
Bijl et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: